Safety concerns prompt Multaq restrictions
September 26, 2011Sales and Marketing Multaq
The European Medicines Agency has recommended Sanofi’s Multaq be restricted due to ongoing concerns about its safety profile. The drug …
Avastin faces greater scrutiny over eye disease use
September 23, 2011Sales and Marketing avastin, macular oedema
The use of Roche’s Avastin to treat eye disease has come under greater scrutiny after a series of infections in …
Carolin Prasmo returns to Aurora
September 23, 2011Medical Communications appointment, medical communications
Farringdon, UK-based comms agency Aurora has appointed Carolin Prasmo as senior account account manager. She was originally one of the …
Virgo Health Education expands scientific and client service teams
September 23, 2011Medical Communications appointment, medical communications
Virgo has expanded its Health Education business unit with the appointments of Jenny Szkolar and Vicky Cadman. Jenny (pictured) joins …
Boehringer censured over Pradaxa marketing
September 23, 2011Medical Communications ABPI Code of Practice, Boehringer
Boehringer Ingelheim has been heavily censured by the body which enforces the ABPI’s Code of Practice for the content of …
Roche cleared over rep conduct complaint
September 23, 2011Sales and Marketing ABPI Code of Practice, Roche
Roche has been cleared by Code regulator the PMCPA of any wrongdoing after an NHS employee complained about the promotion …
Value-based pricing won’t encourage innovation, says ABPI
September 23, 2011Sales and Marketing value-based pricing
The ABPI has come out against the government’s reforms of drug pricing in the UK, saying its plans need a …
NHS ‘wasted’ £625 million on modern insulin
September 23, 2011Sales and Marketing diabetes, insulin
The NHS has wasted £625 million on modern insulin products over the last decade, according to a new report in …
Healthcare 2025: what the future holds for pharma
September 22, 2011Manufacturing and Production, Research and Development, Sales and Marketing NHS reform, healthcare reform, healthcare spending, prescribing
We are in the middle of a huge upheaval where everything we know is being turned on its head. Welcome …
J&J’s hep C drug Incivo approved in Europe
September 22, 2011Sales and Marketing Incivek, Incivo, Victrelis
J&J’s potential blockbuster hepatitis C treatment Incivo has been approved in Europe. Incivo (telaprevir) was approved in combination with peginterferon …
Sanofi spots acne vaccine opportunity
September 22, 2011Research and Development Sanofi, acne, dermatology
Sanofi Pasteur has signed a new research deal with the University of California, San Diego for its investigational acne vaccine. …
Pfizer to cut 11% of its workforce in Spain
September 22, 2011Sales and Marketing Pfizer, Spain, job cuts
Pfizer will cut 220 jobs in Spain as the government reduces spending on pharmaceuticals to help offset its growing debt …
RSA boosts team with new appointments
September 22, 2011Business Services appointment, business services
Global life sciences executive search and interim management firm RSA has made a series of new appointments across its practices. …
Health secretary calls for global action on lifestyle conditions
September 21, 2011cardiovascular, diabetes, respiratory, smoking
Health secretary Andrew Lansley has urged governments across the world to be “bold and determined” in working together to tackle …
NHS reforms face pressure from the Lords
September 21, 2011NHS reform
Peers are starting to voice their criticism of the government’s planned NHS reforms as the Health and Social Bill passes …
Obama proposes seven year rule for biologics
September 21, 2011Research and Development, Sales and Marketing Obama, biologics
President Obama has returned to the issue of market exclusivity for biologic drugs as a way of cutting healthcare costs. …
Silence Therapeutics appoints Thomas Christely
September 21, 2011Research and Development appointment, research and development
UK-headquartered biotech Silence Therapeutics has appointed Thomas Christély as chief executive. He was instrumental in the merger of Silence Therapeutics …
Pfizer to invest $200m in Irish biomanufacturing plant
September 21, 2011Manufacturing and Production Ireland, Pfizer, pharma manufacturing news
Pfizer is planning to invest around €145 million ($200m) at its biomanufacturing facility in Co Dublin, Ireland, according to the …
Janssen’s Zytiga launched in the UK
September 21, 2011Sales and Marketing Zytiga, prostate cancer
Janssen’s new advanced prostate cancer treatment Zytiga has been launched in the UK. Zytiga (abiraterone acetate) has been shown in …
Pharmacovigilance Compliance Report submission; MHRA’s Risk Based Compliance Programme
September 20, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PV, Wainwright Associates
A new version of the MHRA pharmacovigilance Compliance Report (Good Pharmacovigilance Practice Questionnaire) has been released by the MHRA.Submission of …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
